Rabies
📧 Sign up to get email alerts when something new happens for Rabies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-24Clinical Trial Results: Study of Intradermal Administration of PCEC Rabies Vaccine [NA]
Completed clinical trial evaluating intradermal administration of PCEC rabies vaccine for rabies prevention and exposure.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Real World Evidence Study of SYN023 in Children Exposed to Rabies
Real-world evidence study of SYN023 in children exposed to rabies is currently recruiting, aiming to evaluate the product in pediatric post-…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults [Phase 1]
A Phase 1 trial completed evaluating the safety and immunogenicity of two investigational vaccines for Yellow Fever and Rabies in healthy ad…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years [Phase 3]
A Phase 3 clinical trial of a freeze-dried rabies vaccine derived from human diploid cells for individuals aged 10 to 60 years is sponsored …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Adherence to Anti-rabies Post-exposure Prophylactic Protocols
A completed clinical trial evaluating adherence to anti-rabies post-exposure prophylaxis protocols.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell) [Phase 3]
Phase III clinical trial assessing immunogenicity and safety of a lyophilized human diploid cell rabies vaccine in humans; currently enrolli…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming. [Phase 3]
Phase 3 clinical trial update evaluating boosting of three rabies pre-exposure regimens five years after priming in healthy volunteers; the …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody [Phase 2]
Phase II trial of a recombinant human anti-rabies monoclonal antibody is not yet recruiting, indicating early-stage development for rabies p…
-
FDA approval · 2026-02-18FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)
FDA approved a supplemental manufacturing operations application for EBANGA (ansuvimab) held by Emergent Manufacturing Operations Baltimore,…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine [Phase 3]
Phase IIIb trial to evaluate lot-to-lot consistency of Sinovac Rabies Vaccine in healthy volunteers; the study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried [Phase 3]
Phase 3 trial evaluating the immunogenicity and safety of a freeze-dried rabies vaccine produced on Vero cells in healthy volunteers has com…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies [Phase 2]
Phase 2 clinical trial comparing SYN023 to human rabies immune globulin for post-exposure prophylaxis of rabies has completed. Results were …
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: SYN023 With Rabies Vaccine in Healthy Pediatric Subjects [Phase 1]
Phase 1 trial evaluating SYN023 with a rabies vaccine for rabies post-exposure prophylaxis in healthy pediatric subjects has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Safety and Immunogenicity of ID vs IM Rabies Vaccine [Phase 2, Phase 3]
This document outlines a Phase 2/3 clinical trial comparing intradermal versus intramuscular rabies vaccine for safety and immunogenicity, c…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell) [Phase 1]
A Phase 1 trial to evaluate the safety of different immunization schedules for a lyophilized human rabies vaccine (human diploid cell) for r…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years [Phase 1]
The update notes the completion of a Phase 1 clinical trial evaluating a freeze-dried rabies vaccine derived from human diploid cells in par…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine [Phase 2]
This clinical trial update describes a Phase 2 study to evaluate the safety and immunogenicity of coadministration of the candidate ChAdOx2 …
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG [Phase 1, Phase 2]
A Phase Ib/II study evaluating the safety and immunogenicity of the ChAdOx2 RabG rabies vaccine candidate; the trial is currently active but…
-
CLINICAL_TRIALS research · 2025-11-13Clinical Trial Update: Survey of Human Rabies Immune Globulin Safety in Children
A pediatric safety study of Human Rabies Immune Globulin (HRIG) was terminated; no results are reported in this update.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland [Phase 3]
Phase 3 study comparing Purified Vero Rabies Vaccine with a reference rabies vaccine for simulated post-exposure prophylaxis in adults and c…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland [Phase 3]
A Phase 3 trial comparing Purified Vero Rabies Vaccine with a reference rabies vaccine for simulated post-exposure prophylaxis in healthy ad…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
This clinical study evaluates immunogenicity and safety of a lyophilized vero cell–derived human rabies vaccine in special populations and i…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) [Phase 2]
Phase 2 clinical trial evaluating the immunogenicity and safety of different dosages of a serum-free Vero cell–derived rabies vaccine; the s…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen [Phase 3]
This Phase 3 study from Sinovac evaluates the immunogenicity and safety of a serum-free vero cell–based rabies vaccine in a simulated post-e…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen [Phase 3]
A Phase 3 clinical trial evaluating the immunogenicity and safety of a serum-free Vero cell–based rabies vaccine for pre-exposure prophylaxi…